Stryker Corporation (LON:0R2S)
London · Delayed Price · Currency is GBP · Price in USD 371.70
+2.87 (0.78%)
At close: Nov 24, 2025
Stryker Market Cap
Stryker has a market cap or net worth of 108.08 billion as of November 25, 2025. Its market cap has decreased by -1.04% in one year.
Market Cap
108.08B
Enterprise Value
118.60B
Revenue
18.14B
Ranking
n/a
PE Ratio
49.36
Stock Price
371.70
Market Cap Chart
Since June 21, 1983, Stryker's market cap has increased from 126.05M to 108.08B, an increase of 85,642.26%. That is a compound annual growth rate of 17.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 107.61B | -1.85% |
| Dec 31, 2024 | 109.64B | 22.74% |
| Dec 29, 2023 | 89.32B | 16.32% |
| Dec 30, 2022 | 76.79B | 3.07% |
| Dec 31, 2021 | 74.50B | 10.46% |
| Dec 31, 2020 | 67.45B | 13.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 214.31B |
| GSK plc | 71.84B |
| Haleon | 33.59B |
| Smith & Nephew | 10.61B |
| ConvaTec Group | 4.65B |
| Hikma Pharmaceuticals | 3.53B |
| HUTCHMED (China) | 1.86B |
| Genus | 1.65B |